The global nutraceutical excipients market size is estimated at USD 4.90 billion in 2025 and is forecasted to reach around USD 8.95 billion by 2034, accelerating at a CAGR of 6.93% from 2025 to 2034. The North America nutraceutical excipients market size surpassed USD 1.88 billion in 2024 and is expanding at a CAGR of 7.97% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nutraceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nutraceutical Excipients Market, by Functionality
8.1.1. Binder
8.1.1.1. Market Revenue and Forecast
8.1.2. Disintegrants
8.1.2.1. Market Revenue and Forecast
8.1.3. Fillers & Diluents
8.1.3.1. Market Revenue and Forecast
8.1.4. Coating Agent
8.1.4.1. Market Revenue and Forecast
8.1.5. Flavoring Agent
8.1.5.1. Market Revenue and Forecast
8.1.6. Lubricants
8.1.6.1. Market Revenue and Forecast
8.1.7. Others
8.1.7.1. Market Revenue and Forecast
9.1. Nutraceutical Excipients Market, by Product
9.1.1. Prebiotics
9.1.1.1. Market Revenue and Forecast
9.1.2. Probiotics
9.1.2.1. Market Revenue and Forecast
9.1.3. Proteins & Amino Acids
9.1.3.1. Market Revenue and Forecast
10.1. Nutraceutical Excipients Market, by Type
10.1.1. Artificial
10.1.1.1. Market Revenue and Forecast
10.1.2. Natural/Organic
10.1.2.1. Market Revenue and Forecast
11.1. Nutraceutical Excipients Market, by Form
11.1.1. Dry
11.1.1.1. Market Revenue and Forecast
11.1.2. Liquid
11.1.2.1. Market Revenue and Forecast
12.1. Nutraceutical Excipients Market, by End Use
12.1.1. Protein and Amino Acids
12.1.1.1. Market Revenue and Forecast
12.1.2. Omega 3 Fatty Acids
12.1.2.1. Market Revenue and Forecast
12.1.3. Vitamins
12.1.3.1. Market Revenue and Forecast
12.1.4. Minerals
12.1.4.1. Market Revenue and Forecast
12.1.5. Prebiotics and Probiotics
12.1.5.1. Market Revenue and Forecast
12.1.6. Others
12.1.6.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Functionality
13.1.2. Market Revenue and Forecast, by Product
13.1.3. Market Revenue and Forecast, by Type
13.1.4. Market Revenue and Forecast, by Form
13.1.5. Market Revenue and Forecast, by End Use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Functionality
13.1.6.2. Market Revenue and Forecast, by Product
13.1.6.3. Market Revenue and Forecast, by Type
13.1.6.4. Market Revenue and Forecast, by Form
13.1.7. Market Revenue and Forecast, by End Use
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Functionality
13.1.8.2. Market Revenue and Forecast, by Product
13.1.8.3. Market Revenue and Forecast, by Type
13.1.8.4. Market Revenue and Forecast, by Form
13.1.8.5. Market Revenue and Forecast, by End Use
13.2. Europe
13.2.1. Market Revenue and Forecast, by Functionality
13.2.2. Market Revenue and Forecast, by Product
13.2.3. Market Revenue and Forecast, by Type
13.2.4. Market Revenue and Forecast, by Form
13.2.5. Market Revenue and Forecast, by End Use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Functionality
13.2.6.2. Market Revenue and Forecast, by Product
13.2.6.3. Market Revenue and Forecast, by Type
13.2.7. Market Revenue and Forecast, by Form
13.2.8. Market Revenue and Forecast, by End Use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Functionality
13.2.9.2. Market Revenue and Forecast, by Product
13.2.9.3. Market Revenue and Forecast, by Type
13.2.10. Market Revenue and Forecast, by Form
13.2.11. Market Revenue and Forecast, by End Use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Functionality
13.2.12.2. Market Revenue and Forecast, by Product
13.2.12.3. Market Revenue and Forecast, by Type
13.2.12.4. Market Revenue and Forecast, by Form
13.2.13. Market Revenue and Forecast, by End Use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Functionality
13.2.14.2. Market Revenue and Forecast, by Product
13.2.14.3. Market Revenue and Forecast, by Type
13.2.14.4. Market Revenue and Forecast, by Form
13.2.15. Market Revenue and Forecast, by End Use
13.3. APAC
13.3.1. Market Revenue and Forecast, by Functionality
13.3.2. Market Revenue and Forecast, by Product
13.3.3. Market Revenue and Forecast, by Type
13.3.4. Market Revenue and Forecast, by Form
13.3.5. Market Revenue and Forecast, by End Use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Functionality
13.3.6.2. Market Revenue and Forecast, by Product
13.3.6.3. Market Revenue and Forecast, by Type
13.3.6.4. Market Revenue and Forecast, by Form
13.3.7. Market Revenue and Forecast, by End Use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Functionality
13.3.8.2. Market Revenue and Forecast, by Product
13.3.8.3. Market Revenue and Forecast, by Type
13.3.8.4. Market Revenue and Forecast, by Form
13.3.9. Market Revenue and Forecast, by End Use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Functionality
13.3.10.2. Market Revenue and Forecast, by Product
13.3.10.3. Market Revenue and Forecast, by Type
13.3.10.4. Market Revenue and Forecast, by Form
13.3.10.5. Market Revenue and Forecast, by End Use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Functionality
13.3.11.2. Market Revenue and Forecast, by Product
13.3.11.3. Market Revenue and Forecast, by Type
13.3.11.4. Market Revenue and Forecast, by Form
13.3.11.5. Market Revenue and Forecast, by End Use
13.4. MEA
13.4.1. Market Revenue and Forecast, by Functionality
13.4.2. Market Revenue and Forecast, by Product
13.4.3. Market Revenue and Forecast, by Type
13.4.4. Market Revenue and Forecast, by Form
13.4.5. Market Revenue and Forecast, by End Use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Functionality
13.4.6.2. Market Revenue and Forecast, by Product
13.4.6.3. Market Revenue and Forecast, by Type
13.4.6.4. Market Revenue and Forecast, by Form
13.4.7. Market Revenue and Forecast, by End Use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Functionality
13.4.8.2. Market Revenue and Forecast, by Product
13.4.8.3. Market Revenue and Forecast, by Type
13.4.8.4. Market Revenue and Forecast, by Form
13.4.9. Market Revenue and Forecast, by End Use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Functionality
13.4.10.2. Market Revenue and Forecast, by Product
13.4.10.3. Market Revenue and Forecast, by Type
13.4.10.4. Market Revenue and Forecast, by Form
13.4.10.5. Market Revenue and Forecast, by End Use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Functionality
13.4.11.2. Market Revenue and Forecast, by Product
13.4.11.3. Market Revenue and Forecast, by Type
13.4.11.4. Market Revenue and Forecast, by Form
13.4.11.5. Market Revenue and Forecast, by End Use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Functionality
13.5.2. Market Revenue and Forecast, by Product
13.5.3. Market Revenue and Forecast, by Type
13.5.4. Market Revenue and Forecast, by Form
13.5.5. Market Revenue and Forecast, by End Use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Functionality
13.5.6.2. Market Revenue and Forecast, by Product
13.5.6.3. Market Revenue and Forecast, by Type
13.5.6.4. Market Revenue and Forecast, by Form
13.5.7. Market Revenue and Forecast, by End Use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Functionality
13.5.8.2. Market Revenue and Forecast, by Product
13.5.8.3. Market Revenue and Forecast, by Type
13.5.8.4. Market Revenue and Forecast, by Form
13.5.8.5. Market Revenue and Forecast, by End Use
14.1. DuPont14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Cargill Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Shin-Etsu Chemical Co Ltd
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Associated British Foods
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Roquette Freres
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Meggle Group Wasser
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Kerry Group PLC
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Fuji Chemical Industries Co Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. PharmatransSanaq AG
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample